NEW DELHI: Drug firm Cadila Healthcare on Thursday said it has received approval from the USFDA for Haloperidol Decanoate injection used in treatment of schizophrenia. The product will be manufactured ...

Haloperidol (as decanoate) 50mg/mL, 100mg/mL; for IM inj; contains benzyl alcohol. CNS depression potentiated with alcohol (avoid), anesthetics, opioids, other CNS depressants. Possible neurotoxicity ...

Details concerning the Haloperidol Decanoate medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Haloperidol can be administered orally, intramuscularly or intravenously; it is well absorbed from the gastrointestinal tract. First-pass metabolism in the liver reduces the bioavailability to ...

Rockville MD - The US FDA and Johnson & Johnson have informed healthcare professionals of a revision to the prescribing information for haloperidol, an antipsychotic marketed as Haldol, Haldol ...

Among adults with schizophrenia or schizoaffective disorder, treatment with the newer, more costly antipsychotic paliperidone palmitate, compared with the older antipsychotic haloperidol decanoate, ...

Liva Pharmaceuticals, a subsidiary of Cadila Healthcare, has received the Food and Drug Administration’s approval for haloperidol decanoate injection, in dosage strengths of 50 mg (base)/mL and 100 mg ...

Lithium supplements Concomitant use of lithium and antipsychotics, particularly haloperidol, may be associated with neurotoxicity in some patients. Lithium is an effective first-line agent for ...